Featured Articles

1. How To Select The Right Platform For Your Vaccine Production Process 4/16/2026

   Evaluate surface treatments, scalability, and contamination risks to select the right adherent platform. Testing early ensures a seamless transition from benchtop to production.

2. A Journey To Produce MSC-Derived Cell Therapies From Isolation To Large-Scale 2/26/2026

   Drive successful MSC therapy development by optimizing isolation methods, surface chemistry, and closed-system expansion technologies to ensure cellular stability and commercial scalability.

3. Scaling MSC Therapies: Overcoming Cell Therapy Manufacturing Risks And Barriers 2/26/2026

   Achieve scalable MSC manufacturing by implementing closed systems and modular scale-out strategies that minimize contamination risks and ensure consistent cellular stability and efficacy.

4. Manufacturing of "MSC 2.0" Using Functionally Closed Systems 1/27/2026

   Transitioning to closed systems enables the 100-fold expansion of engineered cells. Achieve high yields and maintain anti-cancer potency while reducing contamination risks and labor.

5. Navigating Cell Culture Vessels: A Collection Of Application Notes 1/27/2026

   Discover scalable strategies for high-yield adherent cell culture. Learn how gas-permeable technology optimizes MSC expansion, viral vector production, and extracellular vesicle secretion.

6. Methods For MSC Concentration And Buffer Exchange 11/4/2025

   Effective cell concentration and buffer exchange are crucial in MSC biomanufacturing for safety and efficacy. Compare the trade-offs of centrifugation, filtration, and elutriation to optimize your process.

7. What Are MSCs And How Are They Used? 11/4/2025

   Learn about the defining criteria and varied tissue sources of MSCs. Discover their expanding role in therapies targeting inflammatory conditions and tissue regeneration.

8. Expansion Of Human Bone Marrow-Derived MSCs 11/3/2025

   Achieving over 870 million viable, quality mesenchymal stem/stromal cells is possible. This efficient cell culture method scales bone marrow-derived MSCs for clinical needs.

9. Expansion Of Human Bone Marrow-Derived MSCs 11/3/2025

   Achieving over 870 million viable, quality mesenchymal stem/stromal cells is possible. This efficient cell culture method scales bone marrow-derived MSCs for clinical needs.

10. Maximizing MSC Yield And Quality: A Comparative Media Study 11/3/2025

    Maximize mesenchymal stem cell (MSC) expansion with a simplified culture process. New data demonstrates a high-performance, xeno-free media that eliminates the need for coatings or media exchanges.